Tokyo, Sept. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058902) titled 'A retrospective observational study to investigate the impact of the severity of ptosis on visual functions' on Sept. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Santen Pharmaceutical Co., Ltd.
Condition:
Condition - Ptosis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To exploratorily investigate the impact of the severity of ptosis on visual functions in patients with ptosis through a retrospective observational study.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Fem...